Shanghai Fosun Pharmaceutical (Group) Co (SHSE:600196) Cyclically Adjusted Book per Share: ¥14.56 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:600196 Shanghai Fosun Pharmaceutical (Group) Co Ltd SHSE:600196
78 GF Score
Price ¥24.05
GF Value ¥27.05
Valuation Modestly Undervalued
! 10 Warning Signs
View Full Analysis

What is Shanghai Fosun Pharmaceutical (Group) Co Cyclically Adjusted Book per Share?

Shanghai Fosun Pharmaceutical (Group) Co SHSE:600196 +1.09% 78 Cyclically Adjusted Book per Share is ¥14.56 as of Mar. 2026. GuruFocus rates SHSE:600196 with a GF Score™ of 78/100 and a GF Value™ of ¥27.05 (Modestly Undervalued). The stock has 10 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Shanghai Fosun Pharmaceutical (Group) Co's adjusted book value per share for the three months ended in Mar. 2026 was ¥18.404. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is ¥14.56 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Shanghai Fosun Pharmaceutical (Group) Co's average Cyclically Adjusted Book Growth Rate was 7.90% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was 7.80% per year. During the past 5 years, the average Cyclically Adjusted Book Growth Rate was 9.00% per year. During the past 10 years, the average Cyclically Adjusted Book Growth Rate was 11.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Shanghai Fosun Pharmaceutical (Group) Co was 18.60% per year. The lowest was 7.80% per year. And the median was 15.35% per year.

As of today (2026-07-14), Shanghai Fosun Pharmaceutical (Group) Co's current stock price is ¥24.05. Shanghai Fosun Pharmaceutical (Group) Co's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2026 was ¥14.56. Shanghai Fosun Pharmaceutical (Group) Co's Cyclically Adjusted PB Ratio of today is 1.65.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Shanghai Fosun Pharmaceutical (Group) Co was 8.43. The lowest was 1.46. And the median was 3.69.


Shanghai Fosun Pharmaceutical (Group) Co  (SHSE:600196) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Shanghai Fosun Pharmaceutical (Group) Co's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=24.05/14.56
=1.65

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Shanghai Fosun Pharmaceutical (Group) Co was 8.43. The lowest was 1.46. And the median was 3.69.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Shanghai Fosun Pharmaceutical (Group) Co Cyclically Adjusted Book per Share Related Terms


Shanghai Fosun Pharmaceutical (Group) Co Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for Shanghai Fosun Pharmaceutical (Group) Co's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shanghai Fosun Pharmaceutical (Group) Co Cyclically Adjusted Book per Share Chart

Shanghai Fosun Pharmaceutical (Group) Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 10.27 11.38 12.29 13.24 14.27

Shanghai Fosun Pharmaceutical (Group) Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 13.50 13.70 14.00 14.27 14.56

SHSE:600196 vs ZTS, UTHR: Cyclically Adjusted Book per Share Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Shanghai Fosun Pharmaceutical (Group) Co's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shanghai Fosun Pharmaceutical (Group) Co Cyclically Adjusted PB Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Shanghai Fosun Pharmaceutical (Group) Co's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Shanghai Fosun Pharmaceutical (Group) Co's Cyclically Adjusted PB Ratio falls into.


SHSE:600196
78GF Score
Shanghai Fosun Pharmaceutical (Group) Co Ltd SHSE:600196
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Shanghai Fosun Pharmaceutical (Group) Co Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Shanghai Fosun Pharmaceutical (Group) Co's adjusted Book Value per Share data for the three months ended in Mar. 2026 was:

Adj_Book= Book Value per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=18.404/116.3033*116.3033
=18.404

Current CPI (Mar. 2026) = 116.3033.

Shanghai Fosun Pharmaceutical (Group) Co Quarterly Data

Book Value per Share CPI Adj_Book
201606 8.208 101.400 9.414
201609 8.125 102.400 9.228
201612 9.190 102.600 10.417
201703 9.445 103.200 10.644
201706 9.883 103.100 11.149
201709 10.233 104.100 11.433
201712 10.151 104.500 11.298
201803 10.387 105.300 11.472
201806 10.246 104.900 11.360
201809 11.131 106.600 12.144
201812 10.916 106.500 11.921
201903 11.206 107.700 12.101
201906 11.209 107.700 12.104
201909 11.953 109.800 12.661
201912 12.442 111.200 13.013
202003 12.771 112.300 13.226
202006 12.891 110.400 13.580
202009 12.909 111.700 13.441
202012 14.435 111.500 15.057
202103 14.709 112.662 15.184
202106 14.773 111.769 15.372
202109 15.193 112.215 15.746
202112 15.293 113.108 15.725
202203 14.955 114.335 15.212
202206 14.905 114.558 15.132
202209 16.304 115.339 16.440
202212 16.684 115.116 16.856
202303 16.987 115.116 17.162
202306 17.012 114.558 17.271
202309 17.182 115.339 17.326
202312 17.095 114.781 17.322
202403 17.342 115.227 17.504
202406 17.575 114.781 17.808
202409 17.707 115.785 17.786
202412 17.692 114.893 17.909
202503 17.946 115.116 18.131
202506 17.749 114.907 17.965
202509 17.985 115.471 18.115
202512 18.252 115.832 18.326
202603 18.404 116.303 18.404

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of ¥14.56 mean?
Shanghai Fosun Pharmaceutical (Group) Co (SHSE:600196) has a Cyclically Adjusted Book per Share of ¥14.56 as of Mar. 2026. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Shanghai Fosun Pharmaceutical (Group) Co and its competitors.
Is Shanghai Fosun Pharmaceutical (Group) Co's Cyclically Adjusted Book per Share too high?
Shanghai Fosun Pharmaceutical (Group) Co's current Cyclically Adjusted Book per Share is ¥14.56. Overall, Shanghai Fosun Pharmaceutical (Group) Co has a GF Score™ of 78/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Shanghai Fosun Pharmaceutical (Group) Co's Cyclically Adjusted Book per Share compare to ZTS and UTHR?
Shanghai Fosun Pharmaceutical (Group) Co's Cyclically Adjusted Book per Share of ¥14.56 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Drug Manufacturers company?
A good Cyclically Adjusted Book per Share depends on the Drug Manufacturers industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Shanghai Fosun Pharmaceutical (Group) Co and its competitors. Shanghai Fosun Pharmaceutical (Group) Co's current Cyclically Adjusted Book per Share is ¥14.56. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shanghai Fosun Pharmaceutical (Group) Co stock overvalued right now?
Based on GuruFocus' analysis, Shanghai Fosun Pharmaceutical (Group) Co (SHSE:600196) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥27.05, compared to a current price of ¥24.05 — trading 11.1% below its estimated fair value. The current Cyclically Adjusted Book per Share is ¥14.56. Shanghai Fosun Pharmaceutical (Group) Co's overall GF Score™ is 78/100 with 10 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For Shanghai Fosun Pharmaceutical (Group) Co (SHSE:600196), the current Cyclically Adjusted Book per Share is ¥14.56 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Shanghai Fosun Pharmaceutical (Group) Co (SHSE:600196) Overvalued in 2026?

Based on GuruFocus' analysis, Shanghai Fosun Pharmaceutical (Group) Co stock appears to be undervalued. The current stock price of ¥24.05 is trading 11.1% below its estimated GF Value™ of ¥27.05. GuruFocus considers Shanghai Fosun Pharmaceutical (Group) Co to be Modestly Undervalued.

Key valuation signals for SHSE:600196:

  • Cyclically Adjusted Book per Share: ¥14.56
  • GF Value™: ¥27.05 vs. price of ¥24.05 (11.1% below fair value)
  • GF Score™: 78/100 with 10 warning signs

No single metric tells the full story. See the SHSE:600196 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Shanghai Fosun Pharmaceutical (Group) Co Business Description

Address No. 1289 Yishan Road, Building A, Fosun Technology Park, Shanghai, CHN, 200233
Shanghai Fosun Pharmaceutical (Group) Co Ltd is engaged in the development, manufacture, sale of pharmaceutical products and medical equipment, the import and export of medical equipment, and the provision of related and other consulting services and investment management. Its business segments are Pharmaceutical manufacturing, Healthcare Services, Medical devices, and medical diagnosis. It generates the majority of its revenue from the Pharmaceutical manufacturing segment. The company considers mergers and acquisitions as a potential component of its operational growth for expanding its research, development, manufacturing, and marketing capabilities. Its geographic areas are the Chinese mainland, Regions outside the Chinese mainland, and other countries.
78GF Score

Get the complete analysis for SHSE:600196

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥24.05
Price
¥27.05
GF Value